Influence of tonifying kidney recipe on advanced glycation endproducts and lipid peroxidation in ovariectomized rats

BACKGROUND： Previous studies have demonstrated that reduced estrogen levels may accelerate the formation of advanced glycation endproducts （AGE） in brain tissue, raise the concentration of lipid peroxidation products in vivo, and speed up deterioration of learning and memory. A tonifying kidney recipe is hypothesized to improve the ability of learning and memory in ovariectomized rats by downregulating AGE and lipid peroxidation products. OBJECTIVE： To simulate a postmenopausal state, bilateral ovariectomy （OVX） was performed in rats, and the effects of tonifying kidney recipe （TKR） on AGE and lipid peroxidation in the rat cerebral cortex, hippocampus, and blood serum levels was measured. In addition, the effects on learning and memory were evaluated, and the effect of AGE -specific inhibitor aminoguanidine （AG） was compared with TKR. DESIGN, TIME AND SETTING： A randomized, in vivo, control experiment was performed at the scientific research center （Provincial Key Laboratory） in the Fourth Hospital of Hebei Medical University （Shijiazhuang, Hebei Province, China） from May 2005 to January 2007. MATERIALS： Forty healthy, adult, female, Sprague Dawley rats were used for this study. TKR was composed of prepared rehmannia rhizome, epimedium herb, desert-living cistanche, and Szechwan lovage rhizome, which were provided by Shijiazhuang Medical Materials Company （China）. A TKR extraction was prepared for further use. AG was provided by Sigma （USA）. Forty rats were randomly divided into four groups： sham, OVX, AG, and TKR, with 10 rats in each group. METHODS： The rat ovaries were resected in the OVX, AG, and TKR groups, whereas the same volume of fat was resected in the sham group. At four weeks after OVX, the AG group received 1% AG water solution by lavage; the TKR group was administrated by lavage once per day at a dose of 6.3 g （crude drug）/kg; OVX and sham groups received equal volumes of tap water. MAIN OUTCOME MEASURES： Learning and memory behavior of rats was tested in a Y-electric maze 16 weeks after the OVX procedure. The contents of advanced glycation endproducts in the rat cerebral cortex, hippocampus, serum, and urine were detected by competitive ELISA and spectrofluorophotometer. The contents of lipid peroxidation in rat serum, cerebral cortex, and hippocampus were assayed using a biochemical method. RESULTS： Compared with the sham group, serum content of advanced glycation endproducts in the OVX group was significantly increased, and lipid peroxidation content increased in cerebral cortex, hippocampus, and serum （t = 3.04-4.22, P 〈 0.05 0.01）. Both AG and TKR decreased the amount of AGE in cerebral cortex and serum （t = 2.53, 3.64, P 〈 0.05, 0.01）, increased AGE urine content （t = 3.25 4.87, P 〈 0.01）, and decreased lipid peroxidation content in cerebral cortex, hippocampus, and serum （t = 2.80 3.70, P 〈 0.05 0.01）. In comparison to the OVX and sham groups, the correct escape rate in the Y-electric maze was significantly increased （t = 3.46, 3.28, P 〈 0.01）, and escape latency was significantly decreased （t=3.12, 2.48 P 〈 0.05） in the AG and TKR groups, which indicated that both AG and TKR improved learning and memory The OVX group had a significantly lower correct escape compared with the sham group （t = 4.21, P 〈 0.01 ）.CONCLUSION： The tonifying kidney recipe decreased deposition of advanced glycation endproducts and lipid peroxidation in ovariectomized rats, and concomitantly improved learning and memory. The effect of TKR was equal to that of AG.

Clinical observation of kidney tonifying and collateral tonifying acupuncture combined with thermosensitive moxibustion in the treatment of knee osteoarthritis and its effect on TRACP and CTX-I

Objective:To observe the clinical effect of kidney-tonifying and colllateral-tonifying acupuncture combined with thermosensitive moxibustion in the treatment of knee osteoarthritis and cold congealing syndrome and the effect on Tartrate-resistant Acid Phosphatase(TRACP)andⅠcollagen C-terminal foreign body peptide(CTX-I).Methods:Totally 90 patients with knee osteoarthritis were divided into three groups:acupuncture group,thermosensitive moxibustion group and routine group with 30 cases in each group.In the conventional group,sodium hyaluronate was injected into the joint cavity and diclofenac sustained release tablets were taken orally.Thermosensitive moxibustion group was given thermosensitive moxibustion on the basis of conventional treatment.Acupuncture and moxibustion group in the heat sensitive moxibustion group treatment was given kidney tonifying acupuncture.VAS score,JKOM score and Ly-Sholm knee score were observed before and after treatment and followed up for 2 weeks.The levels of TRACP and CTX-I in serum before and after treatment.Results:Before treatment,there were statistically significant differences in VAS score,JKOM score and Ly-Sholm knee score among all groups(P>0.05).After treatment,the VAS score and JKOM score decreased,and the decrease degree was the greatest in the acupuncture group(P<0.05).Ly-Sholm knee score increased,and the change degree was the greatest in acupuncture group(P<0.05).Before treatment,the levels of TRACP and CTX-I in serum of all groups were significantly different(P>0.05).After treatment,serum TRACP and CTX-I levels were decreased,and the decrease degree was the greatest in acupuncture group(P<0.05).The total effective rates of the acupuncture group,the thermal sensitive moxibustion group and the conventional group were 96.7%,80%and 66.7%,respectively,and the difference between each group was statistically significant(P<0.05).Conclusion:Kidney-tonifying and collature-tonifying acupuncture combined with thermosensitive moxibustion can significantly relieve knee pain and other symptoms of knee osteoarthritis in patients and cold congealing syndrome,which is worthy of clinical promotion.

Meta-analysis of clinical efficacy and safety of kidney Tonifying therapy in the treatment of interstitial lung disease

Objective:To evaluate the efficacy and safety of kidney tonifying therapy in the treatment of Interstitial Lung Disease(ILD).Methods:We searched Wanfang Data,CNKI,CBM,VIP,Pub Med,EMBASE,Web of science and Cochrane Library for Randomized Controlled Trials(RCTs)of kidney tonifying therapy in the treatment of ILD.The retrieval time was from the establishment of the database to December 15,2020.Rev man 5.3 software was used to analyze and summarize the collected literature,and the methodological quality of the included studies was evaluated by the bias risk assessment scale of Cochrane Collaboration Network.Results:A total of 15 articles with 1045 patients were included.The results of meta-analysis showed that compared with the control group treated with conventional western medicine alone,kidney tonifying therapy or combined with conventional western medicine was beneficial to improve the clinical total effective rate[RR=1.33(95%CI 1.24-1.43),P<0.00001].At the same time,compared with the control group treated with routine western medicine,kidney tonifying therapy or combined with routine western medicine can improve cough and wheezing symptoms of patients[MD=-0.62(95%CI-0.78~-0.46),P<0.00001]and MD=-0.79(95%CI-0.18~-0.49),P<0.00001].However,there was no significant improvement in 6-minute walk test and lung function(DLCO%)(P>0.05);only one study reported 7 patients with adverse reactions,but after corresponding treatment,the symptoms were significantly relieved.The analysis of the characteristics of intervention measures in the treatment group showed that there were a total of 80 traditional Chinese medicines involved,of which Shu Dihuang appeared the most frequently,and the tonic drugs were used the most.The two meridians of the lung and kidney appear most frequently.Among the four qi and five flavors,warm and sweet medicines have the highest frequency.Conclusion:Adopting kidney-tonifying method or combined with conventional Western medicine treatment can improve the total clinical effectiveness of patients.Adopting kidney-tonifying method or combined with conventional Western medicine treatment to improve symptoms such as coughing and wheezing.No serious adverse reactions have been reported,and the safety is reliable.Due to the low quality of the included literature,the results of this study need to be verified by high-quality,large sample randomized controlled trials.

Bushen Huoxue method combined with ACEI/ARB in treating diabetic kidney disease (stage Ⅲ):A meta-analysis and trial sequential analysis

Objective:To evaluate the efficiency of Bushen Huoxue method with ACEI/ARB in treating diabetic kidney disease(stageⅢ).Methods:A total of 8 major electronic databases(CNKI,WanFang,VIP,Sinomed,Pubmed,Embase,Cochrane Liberary,Web of Science)were retrieved since the establishment of the database to October 9,2019.Two reviewers extracted data,and assessed the methodological quality of the included studies.The analysis was made by Stata 15.0 and TSA 0.9 softwares.Results:A total of 10 RCT studies were obtained,including 711 patients with diabetic kidney disease of stageⅢ.Meta-analysis showed that the method of Bushen Huoxue with ACEI/ARB could reduce UAER[WMD=-31.24,95%CI(-42.98,-19.51)],β2-GM[WMD=-92.95,95%CI(-166.05,-19.85)],LDL-C[WMD=-0.19,95%CI(0.19,-0.30)].However,there were no significant effect for HbAlc[WMD=-0.08,95%CI(-0.17,-0.00)],Scr[WMD=-12.96,95%CI(-39.82,13.90)],BUN[WMD=-0.14,95%CI(-0.44,0.17)].The result of TSA indicated that the method of Bushen Huoxue with ACEI/ARB was effective in the treatment of diabetic kidney disease of stageⅢ.Conclusion:The study show that the method of Bushen Huoxue with ACEI/ARB can reduce urinary protein,renal tubular injury and LDL-C in patients with diabetic kidney disease of stageⅢ,and had no effect on HbAlc and renal function.But the conclusion of this study needs further research of high quality.

Regulating and tonifying spleen and kidney traditional Chinese medicine in the treatment of chronic uric acid nephropathy: A systematic review

Objective:To systematically evaluate the efficacy and safety of traditional Chinese medicine for regulating spleen and kidney.Methods:We developed a search strategy and then retrieved the database including CNKI,Wanfang data knowledge service platform,VIP journals resource integration service platform,PubMed,Embasefor randomized controlled trial of regulating spleen and kidney traditional Chinese medicine compared with conventional western medicine in the treatment of chronic uric acid nephropathy.The search deadline was set to June 30,2020.For the included literature,we applied the cochrane collaboration network risk bias assessment tool to evaluate the methodological quality,and evaluated the level of evidence according to GRADE standards.Quantitative data was analyzed by RevMan5.3 software,and trial sequential analysis method was used to analyze its efficiency.Results:A total of 709 cases in 10 articles were included.Compared with the control group,the related traditional Chinese medicine group improved the effective rate[RR=1.45,95%CI(1.32,1.58)],reduced the level of UA[MD=-36.24,95%CI(-41.03,-31.45)],BUN[SMD=-1.27,95%CI(-1.47,-1.07)]and SCR[MD=-36.33,95%CI(-55.79,-16.87),P=0.0003],the difference between the two groups was statistically significant(P<0.05).There was no evidence that a significant adverse reaction occurred.The results of TSA analysis showed that the Chinese medicine group had definite evidence for improving the efficiency.According to the GRADE evaluation criteria,the efficiency,UA,BUN and SCR outcome indicators were extremely low-quality evidence.Conclusions:Traditional Chinese medicine for regulating spleen and kidney in the treatment of chronic uric acid nephropathy improved efficiency,reduced the level of UA,BUN,SCR.Meanwhile,the therapy was proved to be safe.Nevertheless,the conclusions need further high-quality evidence to support.

Vitamin D axis: a new target for treatment depression via tonifying kidney of chinese medicine

Accumulating data indicate that kidney tonifying recipe to treat depression patients may significantly reduce clinical symptoms, effectively improve the quality and prognosis of the patient's life. Clinical and experimental studies have suggested that tonifying kidney recipe has multiple targets, and thereby via multiple ways to accomplish antidepressant effect. The tonifying kidney recipe has been used in traditional Chinese medicine to control neurotrophic factor so as to promote the growth, differentiation, maturation of neurons. The tonifying kidney recipe participates in protection of neural plasticity, brain development, immune regulation, and a variety of other physiological processes to act as an antidepressant that has great similarity as vitamin D axis. In this article, we describe the current knowledge to introduct the relationship between kidney deficiency and vitamin D axis, and speculate about the molecular mechanism of tonifying kidney recipe in the treatment of depression by regulating vitamin D axis.

Research Progress of Tonifying Kidney and Promoting Blood Circulation in the Treatment of Steroid-induced Necrosis of Femoral Head

Osteonecrosis of the femoral head is a common disability disease of the hip joint in China,and osteonecrosis of the femoral head caused by hormone factors is the most common,which is related to the gradual increase in the utilization rate of glucocorticoids in recent years.It is a refractory disease in orthopaedics with a poor prognosis.For this disease,the treatment of traditional Chinese medicine has certain advantages.In view of this,the author reads,analyzes and summarizes its materials by searching China Journal full-text Database and Wanfang Database.This paper reviews the mechanism and clinical research progress of tonifying kidney and activating blood circulation in the prevention and treatment of steroid-induced osteonecrosis of the femoral head,hoping to provide help for the clinical treatment of hormone-related osteonecrosis of the femoral head.

Network Meta-analysis of the clinical efficacy and safety of kidney-tonifying and bone-strengthening therapies for the treatment of rheumatoid arthritis with kidney deficiency type

OBJECTIVE: To compare the efficacy and safety of different Traditional Chinese Medicine(TCM)-based kidney-tonifying and bone-strengthening therapies for rheumatoid arthritis(RA). METHODS: The current Bayesian network Meta-analysis compared different TCM-based kidney-tonifying and bone-strengthening therapies for RA. Eight electronic databases and two trial registration platforms were searched. Rev Man 5.4 and Stata 16 software were employed. RESULTS: A total of 42 studies involving 3779 cases were included. The results showed that the most effective intervention for improving efficacy was Wanbi decoction(顽痹汤);Bushen Quhan Zhiwang decoction(补肾祛寒治尪汤) was superior in reducing the incidence of adverse reactions;and Qiwei Tongbi oral liquid(七味通痹口服液) effectively reduced C-reactive protein and erythrocyte sedimentation rate levels.CONCLUSION: Combining TCMs with conventional Western Medicine can improve the clinical efficacy of RA treatments, reduce inflammatory indexes, and result in a higher safety profile. However, this conclusion needs to be verified by more high-quality randomized controlled trials.

Exploration of the effective components and mechanism of Alpinia oxyphylla-Saposhnikovia Radix in the treatment of diabetic kidney disease based on network pharmacology

Objective:Network pharmacology was used to predict the main targets and related mechanism pathways of the key compounds and active ingredients of the Alpinia oxyphylla-Saposhnikovia Radix based on the therapeutic strategy of tonifying kidney and dispelling pathogenic wind for the treatment of diabetic kidney disease(DKD).Methods:The effective components of Alpinia oxyphylla-Saposhnikovia Radix were screened through the data platform of Traditional Chinese Medicine(TCM).After screening effective targets,the disease target gene database was used to obtain targets for DKD,and then gene enrichment analysis to predict relevant signalling pathways after obtaining the key target genes through Venn analysis.Results:There were 324 active components of Alpinia oxyphylla-Saposhnikovia Radix through the data platform of TCM.In addition,Venn analysis showed that there were 48 key target genes for the treatment of DKD.The biological pathways for the action of Alpinia oxyphylla-Saposhnikovia Radix in DKD were closely related to many signaling pathways including NF-kappaB,classical MAP kinase,JNK and P38 MAP kinase,and ERK5.Conclusions:Treatment of DKD with Alpinia oxyphylla-Saposhnikovia Radix based on the therapeutic strategy of tonifying kidney and dispelling pathogenic wind has the characteristics of multi-components,multi-targets and multi-pathways,which could provide new ideas and methods for further researches on the treatment of DKD with Alpinia oxyphylla-Saposhnikovia Radix.

Theoretical Discussion on Treatment of Cubital Tunnel Syndrome Based on Theory of Liver,Spleen and Kidney

Cubital tunnel syndrome is a disease in which ulnar nerve is compressed by its surrounding tissues,and its main clinical manifestations are pain,sensory disturbance and dyskinesia.Its incidence rate is the second highest among peripheral nerve entrapment diseases,and it is one of the common clinical diseases.The theory of liver,spleen and kidney can guide the treatment of cubital tunnel syndrome with traditional Chinese medicine and acupuncture.By discussing the traditional Chinese medicine(TCM)pathogenesis and treatment principles of cubital tunnel syndrome,it provides modern medical theoretical support for TCM treatment of cubital tunnel syndrome.

Professor Fengjie He’s Experience in Treating Polycystic Ovary Syndrome of Kidney Asthenia and Liver Depression

Polycystic ovary syndrome is a common reproductive endocrine metabolic disease in clinic.Professor Fengjie He has accumulated rich clinical experience in the process of diagnosis and treatment of the disease.He believes that the key to the pathogenesis of the disease is the dysfunction of the reproductive axis of“kidney-Tiangui-Chongren-uterus,”which is based on kidney deficiency and involves the liver and spleen.Clinically,patients with kidney deficiency and liver depression are common.The treatment takes tonifying the kidney and regulating the menstrual cycle as the main method,and the clinical effect is very effective.

肾虚血瘀证大鼠模型的建立及补肾活血方补肾益精活血化瘀功效研究

目的:通过建立肾虚血瘀证大鼠模型并基于方证相应研究补肾活血方的补肾益精、活血化瘀功效。方法:将48只雌性SD大鼠随机分为正常对照组、模型组、阳性药组、补肾活血方低剂量组(0.72 g/kg)、补肾活血方中剂量组(1.44 g/kg)、补肾活血方高剂量组(2.89 g/kg),每组8只。除正常对照组外,各组从第1天开始,上午灌胃造模药羟基脲溶液(450 mg/kg),连续14 d,从第4天上午开始加用肾上腺素0.3 mg/(kg·d)皮下注射至第14天,制备大鼠肾虚血瘀模型。观察大鼠的一般状态,检测子宫和卵巢脏器指数、卵泡数目、黄体数量,血清雌二醇(E_(2))、卵泡刺激素(FSH)、抑制素B(INHB)、红细胞(RBC)、血红蛋白(HGB)、红细胞比容(HCT)、血栓素(TXB-2)、内皮素(ET-1)的水平,血浆红细胞压积、红细胞聚集指数、红细胞变形指数。结果:与正常对照组比较,模型组子宫指数和卵巢指数均下降(P<0.001),卵泡数目下降(P<0.05),黄体数目上升(P<0.05),血清E_(2)、FSH含量均降低,INHB含量升高(P<0.001),RBC、HGB、HCT含量均降低(P<0.001),血浆红细胞压积、红细胞聚集指数、红细胞变形指数均升高(P<0.01,P<0.001),血清ET-1、TXB-2含量均升高(P<0.001)。与模型组比较,给药组卵巢指数均上升(P<0.01,P<0.001),而子宫指数除补肾活血方高剂量组,其他给药组均上升(P<0.05);给药组卵泡数目均上升(P<0.05,P<0.01,P<0.001),补肾活血方各剂量组黄体数量降低(P<0.05);给药组血清E_(2)、FSH均升高(P<0.01,P<0.001)、INHB含量均降低(P<0.001),补肾活血方各剂量组RBC、HGB、HCT含量均升高,差异有统计学意义;给药组血清ET-1、TXB-2含量均降低(P<0.001),血浆红细胞压积和红细胞聚集指数均降低(P<0.001),红细胞变形指数除了补肾活血方高剂量组,其余给药组均降低(P<0.05)。结论:首次通过灌胃羟基脲结合皮下注射肾上腺素建立大鼠肾虚血瘀证模型,补肾活血方可以改善卵巢功能和激素水平,具有补肾益精、补血功效,且通过改变血液流变学的异常,改善内皮细胞功能,降低血栓素,从而达到活血化瘀之功。

补肾活血法联合环孢素及雄激素治疗再生障碍性贫血的有效性及安全性的Meta分析

【目的】系统性评价补肾活血法联合环孢素及雄激素方案治疗再生障碍性贫血(aplastic anemia,AA)的临床有效性和安全性。【方法】检索国内外主要数据库中采用补肾活血法联合环孢素及雄激素(试验组)对比环孢素及雄激素(对照组)治疗AA的随机对照试验(randomized controlled trials,RCTs),筛选符合纳入标准的高质量RCTs,采用RevMan 5.3软件进行Meta分析。【结果】共纳入6项研究,涉及365例患者。Meta分析结果显示,试验组治疗AA总有效率显著优于对照组[OR=4.43,95%CI(2.50,7.84);P<0.00001],试验组在改善外周血象指标如血红蛋白(HGB)水平[MD=14.85,95%CI(10.66,19.05);P<0.00001]、白细胞(WBC)水平[MD=0.61,95%CI(0.21,1.01);P=0.003]、血小板(PLT)水平[MD=16.51,95%CI(9.28,23.75);P<0.00001]等方面优于对照组,且未增加多毛症发生率[OR=0.24,95%CI(0.10,0.61);P=0.003]、痤疮发生率[OR=0.30,95%CI(0.13,0.66);P=0.003]、肝功能异常发生率[OR=0.28,95%CI(0.09,0.83);P=0.02]等不良反应。【结论】补肾活血法联合环孢素及雄激素治疗AA在提高临床疗效、改善外周血象方面均优于单纯使用环孢素及雄激素治疗,同时在减轻不良反应方面有一定优势。

补肾祛瘀法对中重度宫腔粘连的抗纤维化作用及经血中细胞外基质降解相关因子的影响

【目的】探究补肾祛瘀法对中、重度宫腔粘连的抗纤维化作用及经血中细胞外基质降解相关因子的影响。【方法】将124例肾虚血瘀证中、重度宫腔粘连并拟行宫腔镜宫腔粘连分离术(TCRA)的患者随机分为研究组和对照组,每组各62例。2组患者均给予TCRA治疗,对照组术后给予黄体酮+戊酸雌二醇片治疗,研究组在对照组的基础上联合补肾祛瘀方(以归肾汤加减)治疗,共治疗3个月经周期。观察2组患者治疗前后月经情况、阴道彩色多普勒超声检查指标、肾虚血瘀证评分和宫腔粘连评分的变化情况,检测2组患者治疗前后的血管内皮生长因子(VEGF)、转化生长因子β1(TGF-β1)、血小板源性生长因子(PDGF)、结缔组织生长因子(CTGF)以及基质金属蛋白酶9(MMP-9)m RNA、基质金属蛋白酶抑制因子1(TIMP-1)mRNA、磷脂酰肌醇-3-羟激酶(PI3K)m RNA、Ⅰ型胶原A1蛋白(COL1A1)mRNA的表达水平,并评估2组患者的临床疗效和安全性。【结果】(1)疗效方面:治疗3个月经周期后,研究组患者的总有效率为93.55%(58/62),对照组为80.65%(50/62),组间比较,研究组的疗效明显优于对照组(P<0.05)。(2)月经情况方面,治疗后,2组患者的月经经量、周期、经期均较治疗前明显改善(P<0.05),且研究组患者治疗后的月经经量、周期、经期的恢复情况均明显优于对照组(P<0.05)。(3)阴道彩色多普勒超声检查方面,治疗后,2组患者的子宫血流指数(FI)、搏动指数(PI)、阻力指数(RI)、宫腔容积、子宫内膜厚度等均较治疗前明显改善(P<0.05),其中,研究组患者治疗后的FI、宫腔容积、子宫内膜厚度均明显高于对照组,PI、RI均明显低于对照组(P<0.05或P<0.01)。(4)宫腔粘连评分和肾虚血瘀证评分方面,治疗后,2组患者的宫腔粘连评分和肾虚血瘀证评分均较治疗前明显下降(P<0.05),且研究组患者治疗后的宫腔粘连评分和肾虚血瘀证评分均明显低于对照组(P<0.01)。(5)相关因子表达方面,治疗后,2组患者的VEGF、TGF-β1、PDGF、CTGF水平均较治疗前明显下降(P<0.05),且研究组患者治疗后的VEGF、TGF-β1、PDGF、CTGF水平均明显低于对照组(P<0.01)。(6)相关蛋白基因表达方面,治疗后,2组患者经血中MMP-9、PI3K m RNA相对表达量均较治疗前明显上升(P<0.05),COL1A1 mRNA相对表达量均较治疗前明显下降(P<0.05),其中研究组患者治疗后经血中MMP-9、PI3K mRNA相对表达明显高于对照组(P<0.05或P<0.01)。(7)安全性方面,对照组的不良反应总发生率为25.81%(16/62),研究组为16.13%(10/62);组间比较,差异无统计学意义(P>0.05),且经对症处理后,2组患者的不良反应症状均消失,同时研究过程中未见与服用中药相关的不良反应。【结论】补肾祛瘀方联合西药治疗宫腔粘连TCRA术后患者较单用西药治疗效果更佳,加用补肾祛瘀方可进一步促进患者月经恢复,改善子宫内膜血流循环,增加子宫内膜厚度,调节患者体内纤维化因子表达,并可上调PI3K、MMP-9 mRNA表达,恢复患者细胞外基质(ECM)平衡,预防宫腔再粘连,且临床使用安全。

补肾祛瘀法治疗子宫内膜异位症的临床研究

用补肾祛瘀法治疗子宫内膜异位症258例,结果痛经有效率92.64％,不孕治愈率62.39％,包块缩小率75.31％。实验室检查表明,子宫内膜异位症患者在血液流变学、内分泌功能、体液免疫等方面存在异常,经治疗后这些异常指标均得到显著改善。

补肾壮骨冲剂治疗绝经后妇女骨质疏松疼痛的效果分析

【目的】观察补肾健脾基础上加强化瘀药物制成的补肾壮骨冲剂对绝经后妇女骨质疏松疼痛程度的影响。【方法】按数码随机表将178例患者随机分为2组,补肾壮骨冲剂组88例,失访8例;密盖息组90例,失访4例。补肾壮骨冲剂组给予口服补肾壮骨冲剂(由生地、淮山药、山萸肉、泽泻、茯苓、肉桂、淫羊藿、鹿角胶、龟胶、巴戟天、骨碎补、三棱、水蛭等组成);密盖息组给予密盖息肌肉注射治疗。分别于治疗前和治疗1、2、3、4、6周观察两组的疼痛强度、疼痛缓解度、镇痛有效率。【结果】①疼痛强度比较:与治疗前比较,所有患者治疗后疼痛显著性好转(P<0.01);组间比较:治疗第1、2、3周密盖息组疼痛强度低于补肾壮骨冲剂组(P<0.05),而治疗第4、6周两组无显著性差异(P>0.05)。②疼痛缓解情况比较:治疗第1周,补肾壮骨冲剂组未缓解率显著性高于密盖息组(P<0.01),其余则无显著性差异(P>0.05);③有效率比较:除治疗第2周补肾壮骨冲剂组显效率低于密盖息组(P<0.01)外,其他均无显著性差异(P>0.05)。【结论】补肾壮骨冲剂可明显缓解绝经后妇女骨质疏松患者的疼痛,其疗效与密盖息相仿。

补肾化瘀方对PCOS大鼠子宫内膜整合素αvβ3及LIF表达的影响

目的观察补肾化瘀方对多囊卵巢综合征(PCOS)大鼠子宫内膜整合素αvβ3及白血病抑制因子(LIF)的影响。方法100只SD大鼠随机分为25只为空白对照组,75只为模型制备组,予颈背部皮下注射脱氢表雄酮(dehydroepiandrostexone,DHEA)溶液建立PCOS大鼠模型,判定造模成功后随机分为模型对照组、达英-35组、补肾化瘀方组,分别用蒸馏水、达英-35及补肾化瘀方对大鼠灌胃给药,连续灌胃21 d,停药7 d为1周期,3个周期后停药,按雌雄鼠1∶1合笼,并于妊娠第4天处死大鼠,采用免疫组化法检测PCOS大鼠子宫内膜整合素αvβ3及LIF的表达。结果 (1)与空白对照组比较,模型对照组、达英-35组、补肾化瘀方组整合素αvβ3表达均较低(P<0.05);与模型对照组比较,补肾化瘀方组整合素αvβ3较高(P<0.05),达英-35组整合素αvβ3较低(P>0.05)。(2)与空白对照组比较,模型对照组和达英-35组LIF较低(P<0.05);与模型对照组比较,补肾化瘀方组LIF较高(P<0.05)。结论补肾化瘀方可提高PCOS大鼠子宫内膜整合素αvβ3及LIF的表达,这可能是其改善子宫内膜容受性的机制之一。

补肾调经系列方对功能失调性子宫出血患者生殖激素及子宫内膜激素受体的影响

目的探讨补肾调经系列方对功能失调性子宫出血患者生殖激素及子宫内膜雌激素受体(ER)、孕激素受体(PR)的影响。方法运用补肾调经系列方周期给药对39例功能失调性子宫出血患者进行治疗,采用磁分离酶免激素定量测定法测定患者治疗前后血浆雌二醇(E2)、孕酮(P)、促卵泡素(FSH)、黄体生成素(LH);采用流式细胞术测定子宫内膜ER、PR。结果与治疗前相比,治疗后患者子宫内膜ER表达量明显降低(P<0.05),E2水平明显升高(P<0.01)。结论补肾调经系列方有调节生殖激素和子宫内膜ER的作用。

补肾活血系列方对血管性痴呆小鼠脑组织bFGF mRNA表达的影响

目的探讨补肾活血方、补肾方、活血方对血管性痴呆小鼠学习记忆能力及脑组织碱性成纤维细胞生长因子(bFGF)mRNA表达的影响。方法采用脑缺血再灌注法复制血管性痴呆小鼠模型,以尼莫地平为阳性对照组,观察补肾方、活血方、补肾活血方3组小鼠水迷宫法行为学、脑组织bFGF含量及bFGF mRNA表达的变化。结果与假手术组比较,模型组小鼠学习与记忆能力下降,表现为游全程时间延长,错误次数增加(P<0.01),脑组织bFGF含量和bFGF mRNA表达相对含量明显升高(P<0.05或P<0.01);与模型组比较,各治疗组学习成绩和记忆成绩均有明显提高(P<0.05或P<0.01),脑组织bFGF含量和bFGF mRNA表达相对含量明显升高(P<0.01);各治疗组比较,补肾活血组的学习成绩与记忆成绩优于其他治疗组(P<0.05),bFGF含量及脑组织bFGF mRNA表达相对含量均高于活血组(P<0.05),与补肾组比较无统计学差异(P>0.05)。结论补肾方、活血方、补肾活血方均可通过促进脑组织bFGF mRNA表达,提高脑组织bFGF含量,改善血管性痴呆小鼠学习记忆能力,且补肾活血方在促进小鼠学习记忆能力方面显著优于补肾方和活血方,在调节bFGF含量及bFGFmRNA表达方面明显优于活血方。

补肾壮筋汤治疗肝肾亏虚型膝骨关节炎的临床研究

目的:探讨补肾壮筋汤治疗肝肾亏虚型膝骨关节炎的临床疗效。方法:将220例膝骨关节炎患者随机分为治疗组和对照组,每组110例。治疗组口服补肾壮筋汤治疗,对照组口服盐酸氨基葡萄糖胶囊治疗。2组均以12周为1个疗程。观察2组及治疗前后疼痛视觉模拟评分法(VAS)评分、西安大略和麦马斯特大学(WOMAC)骨关节炎指数的变化。结果:治疗组完成101例,脱落9例;对照组完成97例,脱落13例。2组脱落率比较,差异无统计学意义(P>0.05)。治疗组优22例,良45例,中20例,差14例,优良率为66.34%,总有效率为86.14%;对照组优16例,良34例,中32例,差15例,优良率为51.55%,总有效率为84.54%。治疗组优良率明显高于对照组(P<0.05);2组总有效率比较,差异无统计学意义(P>0.05)。治疗后,2组VAS评分与WOMAC骨关节炎指数均有明显改善(P<0.01),且治疗组优于对照组(P<0.05)。结论:补肾壮筋汤能有效缓解肝肾亏虚型膝骨关节炎的临床症状,改善关节功能。